PFE)/BioNTech (Nasdaq: BNTX) COVID-19 vaccine, to be delivered from the second half of next year. This adds to the 100 million doses of the vaccine, now trade named Comirnaty, that the British government has already contracted to buy.
The value of the contract was not disclosed, but early this month Pfizer raised the price of the vaccine to19.50 euros ($23.13) per dose versus 15.50 euros previously
The government, through the Vaccine Taskforce, is putting in place preparations to future-proof the country from the threat of COVID-19 and its variants through safe and effective vaccines, as the UK’s world-renowned vaccination program continues to protect the population.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze